Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 15/20 | 0.70 |
| ▸ | CYP1A1 | P04798 | 14/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 14/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.58 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.58 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.58 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.58 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.58 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3627239 | 0.83 | CYP1A2 (0.70) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL7003172 | 0.83 | CYP1A2 (0.70) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL30411244 | 0.83 | CYP1A2 (0.70) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL25706432 | 0.83 | CYP1A2 (1.00) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL145083 | 0.83 | CYP1A2 (0.76) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL1547597 | 0.81 | CYP1A2 (0.73) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL18901736 | 0.80 | CYP1A2 (0.46) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL11108516 | 0.79 | CYP1A2 (0.70) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL26924044 | 0.79 | CYP1A2 (0.84) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 | |
| SCHEMBL9545111 | 0.79 | CYP1A2 (0.70) | CYP1A2CYP1A1CYP1B1ALDH1A1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4699986-A | AZETIDINE INTERMEDIATES FOR ISOCEPHALOSPORINS | HOFMANN-LA ROCHE INC. (US) | 1987-10-13 | — | — | US | claimed |
| EP-0156976-B1 | OPTICALLY UNIFORM IMINES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1987-09-30 | — | — | EP | claimed |
| CN-109983128-A | Oligonucleotide composition and its method | 波涛生命科学有限公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-109477108-A | Oligonucleotide composition and its method | 波涛生命科学有限公司 | 2019-03-15 | — | — | CN | disclosed |
| EP-2598511-B1 | NOVEL STABLE AND HIGHLY TUNABLE METATHESIS CATALYSTS | ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) | 2018-07-04 | — | — | EP | disclosed |
| CN-108135921-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-108137492-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-108025089-A | Oligonucleotide composition and its method | 波涛生命科学有限公司 | 2018-05-11 | — | — | CN | disclosed |
| US-9815849-B2 | Compositions and methods for treating leukemia | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-11-14 | — | — | US | disclosed |
| CN-103889224-B | ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE | PTC医疗公司 | 2017-05-24 | — | — | CN | disclosed |
| EP-3112353-A1 | SUBSTITUTED IMIDAZOLIUM SULFURANES AND THEIR USE | Studiengesellschaft Kohle MbH (DE) | 2017-01-04 | — | — | EP | disclosed |
| CN-1014244-B | PREPN. OF SYMMETRY (S)-GLUCERALDEHYDE ACELONIDE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1991-10-09 | — | — | CN | disclosed |
| US-4948898-A | MICROBIOCIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 1990-08-14 | — | — | US | disclosed |
| US-4816582-A | BACTERICIDES, ANTIBIOTICS | HOFFMANN-LA ROCHE INC. (US) | 1989-03-28 | — | — | US | disclosed |
| US-4699986-A | AZETIDINE INTERMEDIATES FOR ISOCEPHALOSPORINS | HOFMANN-LA ROCHE INC. (US) | 1987-10-13 | — | — | US | disclosed |
| US-4652651-A | Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage | HOFFMANN-LA ROCHE INC. (US) | 1987-03-24 | — | — | US | disclosed |
| CN-85101931-A | The preparation method of symmetry (S)-Glycerose acetonide | — | 1987-01-24 | — | — | CN | disclosed |
| US-4619787-A | Beta lactams | HOFFMANN-LA ROCHE INC. (US) | 1986-10-28 | — | — | US | disclosed |
| US-4617150-A | MICROBIOCIDES | HOFFMANN-LA ROCHE INC. (US) | 1986-10-14 | — | — | US | disclosed |
| US-4576751-A | ANTIBIOTICS | HOFFMAN-LA ROCHE INC. (US) | 1986-03-18 | — | — | US | disclosed |